Cortes, J., Johnston, S. R. D., Martin, M., Tolaney, S. M., Goetz, M. P., Rugo, H. S., Sohn, J., Ozyilkan, O., Abreu, M. H., Zaiss, M., Vianna, K. M.
, Nielsen, H. M., Chan, A., Kalofonos, H., Morales, S., Grimes, B. R., Amdur, S. & Neven, P. (2026).
Abemaciclib plus endocrine therapy in HR-positive, HER2-negative high-risk early breast cancer: efficacy in nodal subgroups.
ESMO Open,
11(10), Article 108549.
https://doi.org/10.1016/j.esmoop.2026.108549